Remed ē Implantable System FDA Approved to Treat Moderate to Severe Central Sleep Apnea

The FDA has granted Respicardia, a company out of Minnetonka, Minnesota, approval to introduce its Remedē implantable sleep apnea treatment system. The Remedē treats sleep apnea by stimulating one of the phrenic nerves that regulates the activi...

Source: Medgadget - October 9, 2017 Category: Medical Devices Authors: Editors Tags: Cardiology Medicine Radiology Source Type: blogs